Methanesulfonyl fluoride
Alternative Names: SNX-001Latest Information Update: 17 Sep 2015
At a glance
- Originator The University of Texas at El Paso
- Developer SeneXta Therapeutics; University of Texas at El Paso
- Class Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Alzheimer's disease; Cognition disorders
Most Recent Events
- 10 Jan 2011 Methanesulfonyl fluoride is available for licensing as of 10 Jan 2011. http://www.senexta.com/